Latest News for: NTM
Edit
Healthcare Triangle, Inc. Signs Definitive Agreement with Teyame AI LLC which is forecasted to generate $38M in incremental NTM Revenue and incremental NTM EBITDA of $5M in addition to expanding its SaaS Footprint in Europe and Latin America
PR Newswire 22 Jan 2026
PLEASANTON, Calif., Jan. 22, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq ... Notwithstanding the closing timeline, the parties agreed that the transaction contemplated by this Agreement shall be deemed effective as of January 1st, 2026 ... 21% ... .
Edit
TREASURY SHARES BUYBACK INFORMATION 5 JANUARY – 9 JANUARY 2026 PERIOD (Fine Foods & Pharmaceuticals NTM SpA)
Public Technologies 12 Jan 2026
) TREASURY SHARES BUYBACK INFORMATION. 5 JANUARY - 9 JANUARY 2026 PERIOD. Verdellino (Bergamo, Italy), 12 January 2026 - Fine Foods & Pharmaceuticals N.T.M. S.p.A ... S.p.A ... Date. Market. Name. Purchase-. Sale. No ... A ... Fine Foods & Pharmaceuticals NTM S.p.A.
Edit
IDWeek: Annual Meeting 2025 Highlights - Covering HIV, COVID-19, RSV, NTM, UTIs, and More - ResearchAndMarkets.com
Business Wire 02 Dec 2025
Edit
Global NTM Infections Pipeline Poised for Growth as Breakthrough Therapies Advance Toward Late-Stage Development, states DelveInsight
GetNews 20 Nov 2025
Edit
TREASURY SHARES BUYBACK INFORMATION 10 NOVEMBER – 14 NOVEMBER 2025 PERIOD (Fine Foods & Pharmaceuticals NTM SpA)
Public Technologies 17 Nov 2025
) TREASURY SHARES BUYBACK INFORMATION. 10 NOVEMBER - 14 NOVEMBER 2025 PERIOD. Verdellino (Bergamo, Italy), 17 November 2025 - Fine Foods & Pharmaceuticals N.T.M. S.p.A ... S.p.A ... Date. Market. Name. Purchase-. Sale ... Fine Foods & Pharmaceuticals NTM S.p.A.
Edit
Interim Financial Report as of 30 September 2025 (Fine Foods & Pharmaceuticals NTM SpA)
Public Technologies 11 Nov 2025
) FINE FOODS & PHARMACEUTICALS N.T.M. S.p.A. Registered office. VIA BERLINO 39 VERDELLINO (BG) Registered in the BERGAMO Companies Register. Tax code and company reference number ... 09320600969 ... page. 3 ... ". 5 ... Fine Foods & Pharmaceuticals NTM S.p.A.
Edit
Caledonian Record
10 Nov 2025
MannKind Provides Update on Phase 3 ICoN-1 Trial of Nebulized Clofazimine for NTM Lung Disease
Caledonian Record
10 Nov 2025
MannKind has made the decision to discontinue the ICoN-1 ...
Edit
TREASURY SHARES BUYBACK INFORMATION 3 NOVEMBER – 7 NOVEMBER 2025 PERIOD (Fine Foods & Pharmaceuticals NTM SpA)
Public Technologies 10 Nov 2025
) TREASURY SHARES BUYBACK INFORMATION. 3 NOVEMBER - 7 NOVEMBER 2025 PERIOD. Verdellino (Bergamo, Italy), 10 November 2025 - Fine Foods & Pharmaceuticals N.T.M. S.p.A ... S.p.A ... Date. Market. Name. Purchase-. Sale ... P ... Fine Foods & Pharmaceuticals NTM S.p.A.
Edit
9M 2025 Results Presentation (Fine Foods & Pharmaceuticals NTM SpA)
Public Technologies 06 Nov 2025
Edit
Fine Foods confirms growth trajectory: revenue 7%, Adjusted EBITDA was €30.5 million ( 30.2%) and Adjusted EBITDA Margin 16.1% (Fine Foods & Pharmaceuticals NTM SpA)
Public Technologies 06 Nov 2025
). The Board of Directors of Fine Foods & Pharmaceuticals N.T.M. S.p.A. today reviewed and approved the 30 September 2025 Half-Year Financial Report. Fine Foods confirms growth trajectory. revenue +7%, ... *** ... - ... Fine Foods & Pharmaceuticals NTM S.p.A.
Edit
TREASURY SHARES BUYBACK INFORMATION 13 OCTOBER – 17 OCTOBER 2025 PERIOD (Fine Foods & Pharmaceuticals NTM SpA)
Public Technologies 20 Oct 2025
) TREASURY SHARES BUYBACK INFORMATION. 13 OCTOBER - 17 OCTOBER 2025 PERIOD. Verdellino (Bergamo, Italy), 20 October 2025 - Fine Foods & Pharmaceuticals N.T.M. S.p.A ... S.p.A ... Date. Market. Name. Purchase-. Sale. No ... Fine Foods & Pharmaceuticals NTM S.p.A.
- 1
